Table 1.
Summary of demographic baseline characteristics of the efficacy population
| Variable | Total | Female | Male | |||
|---|---|---|---|---|---|---|
| N (%) | 30 | (100.0) | 12 | (40.0) | 18 | (60.0) |
| Age (years) | ||||||
| n (%) | 30 | (100.0) | 12 | (40.0) | 18 | (60.0) |
| Median (IQR) | 67.0 | (60.0, 75.8) | 68.5 | (61.5, 73.5) | 65.0 | (58.5, 78.0) |
| Height (cm) | ||||||
| n (%) | 29 | (96.7) | 12 | (41.4) | 17 | (58.6) |
| Median (IQR) | 163.0 | (158.0, 169.0) | 157.0 | (154.2, 161.2) | 168.0 | (164.0, 179.0) |
| Weight (kg) | ||||||
| n (%) | 29 | (96.7) | 11 | (37.9) | 18 | (62.1) |
| Median (IQR) | 66.0 | (56.0, 79.0) | 62.1 | (52.2, 70.5) | 67.0 | (57.2, 79.8) |
| Chemotherapy regimen, n (%) | ||||||
| Every 2 weeks | 19 | (65.5) | 9 | (81.8) | 10 | (55.6) |
| Every 3 weeks | 5 | (17.2) | 2 | (18.2) | 3 | (16.7) |
| Every week | 5 | (17.2) | 0 | (0.0) | 5 | (27.8) |
| Gastrointestinal neoplasia, n (%) | ||||||
| High | 7 | (23.3) | 2 | (16.7) | 5 | (27.8) |
| Low | 23 | (76.7) | 10 | (83.3) | 13 | (72.2) |
Abbreviation: IQR, interquartile range.